Login to Your Account

Durect, Nycomed Agree On Pain Drug Marketing Deal

By Trista Morrison

Friday, December 1, 2006
Shares of Durect Corp. rose nearly 50 percent in after-close trading Wednesday based on a $202 million marketing deal between the Cupertino, Calif.-based company and Roskilde, Denmark-based Nycomed A/S. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription